Francois Nicolas is a seasoned executive with extensive experience in the healthcare and medical technology sectors. As of May 2024, Francois serves as a Board Observer for NUCLIDIUM AG, contributing to precision oncology innovations. Currently, Francois is the Chairman of the Board for Intrasense, facilitating the integration of AI solutions with medical expertise. Francois has held a director role at Caranx Medical, focusing on surgical robotics, and has been a Board member at Artedrone, which is pioneering microrobotic platforms for interventional neuroradiology. In a senior leadership capacity at Guerbet since September 2017, Francois oversees R&D and digital/AI strategy. Previous roles include COO at Impeto Medical, Vice President at Sanofi, and various senior positions at GE Healthcare, leading initiatives across neurology PET and quality assurance. Francois holds an engineering degree and a PhD in Physics from École Polytechnique.